Medindia

X

Promising Results Anchor Tobira's New CCR5 As Potent Player Among Future HIV Treatments on the Horizon

Thursday, February 18, 2010 General News J E 4
Advertisement
Data presented at the 2010 Conference on Retroviruses & Opportunistic Infections (CROI) showcase new directions in management of HIV disease, including emerging therapies that show promise as potent, safe, convenient and may minimize long-term toxicities.

HIV EXPERTS AVAILABLE FOR INTERVIEW

The following experts are available to provide insights and perspective on the evolving landscape of HIV treatments, the relevance of CCR5s and potential unique properties of TBR-652, based on preliminary data presented at CROI.

/PRNewswire -- Feb. 17/

-- Calvin Cohen, MD, M.Sc., Director of Research, Community Research Initiative of New England -- Kathleen Squires, MD, Professor of Medicine, Jefferson Medical College -- Gerd Fatkenheuer, MD, Head of Infectious Disease, University of Cologne -- Alan Landay, PhD, Director, Developmental Center for AIDS Research -- Jerome Ernst, MD, Medical Director, AIDS Community Research Initiative of America

SOURCE Tobira Therapeutics, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
FDA Warns About Serious Side Effects From Maalox P...
S
Brown & Toland Donates $20,246 to Partners In Heal...